Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | AZD5312 |
Synonyms | |
Therapy Description |
AZD5312 is an antisense oligonucleotide targeted against androgen receptor (AR), potentially resulting in decreased proliferation and increased apoptosis in AR overexpressing tumors (European Journal of Cancer, Volume 69, S145, PMID: 30462924). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
AZD5312 | ISIS-ARRx|ISIS-AZ1Rx|ARRx|AZD-5312 | Antisense Therapy 14 | AZD5312 is an antisense oligonucleotide targeted against androgen receptor (AR), potentially resulting in decreased proliferation and increased apoptosis in AR overexpressing tumors (European Journal of Cancer, Volume 69, S145, PMID: 30462924). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|